Human Epidemiology and Response to SARS-CoV-2 (HEROS): objectives, design, and enrollment results of a 12-city remote observational surveillance study of households with children, using direct-to-participant methods
Patricia C Fulkerson,Stephanie J Lussier,Casper G Bendixsen,Sharon M Castina,Tebeb Gebretsadik,Jessica S Marlin,Patty B Russell,Max A Seibold,Jamie L Everman,Camille M Moore,Brittney M Snyder,Kathy Thompson,George S Tregoning,Stephanie Wellford,Samuel J Arbes,Leonard B Bacharier,Agustin Calatroni,Carlos A Camargo Jr,William D Dupont,Glenn T Furuta,Rebecca S Gruchalla,Ruchi S Gupta,Gurjit Khurana Hershey,Daniel J Jackson,Christine C Johnson,Meyer Kattan,Andrew H Liu,Liza Murrison,George T O’Connor,Wanda Phipatanakul,Katherine Rivera-Spoljaric,Marc E Rothenberg,Christine M Seroogy,Stephen J Teach,Edward M Zoratti,Alkis Togias,Tina V Hartert,
DOI: https://doi.org/10.1093/aje/kwae077
2024-05-21
American Journal of Epidemiology
Abstract:Abstract The Human Epidemiology and Response to SARS-CoV-2 (HEROS) Study is a prospective, multicity, 6-month incidence study conducted from May 2020 to February 2021. The objectives were to identify risk factors for SARS-CoV-2 infection and household transmission among children and people with asthma and allergic diseases, and to use the host nasal transcriptome sampled longitudinally to understand infection risk and sequelae at the molecular level. To overcome challenges of clinical study implementation due to the coronavirus pandemic, this surveillance study used direct-to-participant methods to remotely enroll and prospectively follow eligible children who are participants in other National Institutes of Health–funded pediatric research studies and their household members. Households participated in weekly surveys and biweekly nasal sampling regardless of symptoms. The aim of this report is to widely share the methods and study instruments and to describe the rationale, design, execution, logistics, and characteristics of a large, observational, household-based, remote cohort study of SARS-CoV-2 infection and transmission in households with children. The study enrolled a total of 5598 individuals, including 1913 principal participants (children), 1913 primary caregivers, 729 secondary caregivers, and 1043 other household children. This study was successfully implemented without necessitating any in-person research visits and provides an approach for rapid execution of clinical research. Trial registration: ClinicalTrials.gov. Identifier: NCT04375761
public, environmental & occupational health